Login / Signup

Percutaneous patent foramen ovale closure using the Occlutech Figulla device: More than 1,300 patient-years of follow up.

Roel J R SnijderLaura E RenesMaarten Jan SuttorpJurrien M Ten BergMartijn C Post
Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2018)
The Occlutech device appears to be safe at long-term FU with a very low annual cerebrovascular event rate and a low moderate to large shunt rate at 1-year FU.
Keyphrases
  • case report
  • pulmonary artery
  • coronary artery
  • radiofrequency ablation
  • pulmonary arterial hypertension